Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Matthews

Showing results (51-60 of 84) with videos related to

Pageof 9
Sort By:
International Journal of Radiation Oncology, Biology, Physics|August 11, 2007
A nomogram to predict radiation pneumonitis, derived from a combined analysis of RTOG 9311 and institutional dataJeffrey D Bradley, Andrew Hope, Issam El Naqa, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|February 15, 2017
Day-time variation of serum periostin in asthmatic adults treated with ICS/LABA and adults without asthmaRachel Caswell-Smith, Terrianne Cripps, Thom Charles, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 27, 2013
Paradoxical metastatic progression following 3 months of neo-adjuvant androgen suppression in the TROG 96.01 trial for men with locally advanced prostate cancerJames W Denham, Allison Steigler, Keen-Hun Tai, et al.
Prostate Cancer|January 16, 2013
Risk Stratification after Biochemical Failure following Curative Treatment of Locally Advanced Prostate Cancer: Data from the TROG 96.01 TrialAllison Steigler, James W Denham, David S Lamb, et al.
The European Respiratory Journal|May 3, 2017
The future of asthma research and development: a roadmap from the European Asthma Research and Innovation Partnership (EARIP)Sarah Masefield, Jessica Edwards, Kjeld Hansen, et al.
Orthopaedic Journal of Sports Medicine|March 20, 2019
Association Between Bone Marrow Lesions, Chondral Lesions, and Pain in Patients Without Radiographic Evidence of Degenerative Joint Disease Who Underwent Arthroscopic Partial MeniscectomyLeslie J Bisson, Paul Phillips, John Matthews, et al.
The Lancet. Oncology|March 29, 2011
Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trialJames W Denham, Allison Steigler, David S Lamb, et al.
American Journal of Respiratory and Critical Care Medicine|June 3, 2004
Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthmaRatko Djukanović, Susan J Wilson, Monica Kraft, et al.
Leukemia & Lymphoma|January 30, 2010
A randomized phase I clinical and biologic study of two schedules of sorafenib in patients with myelodysplastic syndrome or acute myeloid leukemia: a NCIC (National Cancer Institute of Canada) Clinical Trials Group StudyMichael Crump, David Hedley, Suzanne Kamel-Reid, et al.
The Lancet. Oncology|October 22, 2008
Time to biochemical failure and prostate-specific antigen doubling time as surrogates for prostate cancer-specific mortality: evidence from the TROG 96.01 randomised controlled trialJames W Denham, Allison Steigler, Chantelle Wilcox, et al.
Pageof 9

Showing results (51-60 of 84) with videos related to

Sort By:
Pageof 9
International Journal of Radiation Oncology, Biology, Physics|August 11, 2007
A nomogram to predict radiation pneumonitis, derived from a combined analysis of RTOG 9311 and institutional dataJeffrey D Bradley, Andrew Hope, Issam El Naqa, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|February 15, 2017
Day-time variation of serum periostin in asthmatic adults treated with ICS/LABA and adults without asthmaRachel Caswell-Smith, Terrianne Cripps, Thom Charles, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 27, 2013
Paradoxical metastatic progression following 3 months of neo-adjuvant androgen suppression in the TROG 96.01 trial for men with locally advanced prostate cancerJames W Denham, Allison Steigler, Keen-Hun Tai, et al.
Prostate Cancer|January 16, 2013
Risk Stratification after Biochemical Failure following Curative Treatment of Locally Advanced Prostate Cancer: Data from the TROG 96.01 TrialAllison Steigler, James W Denham, David S Lamb, et al.
The European Respiratory Journal|May 3, 2017
The future of asthma research and development: a roadmap from the European Asthma Research and Innovation Partnership (EARIP)Sarah Masefield, Jessica Edwards, Kjeld Hansen, et al.
Orthopaedic Journal of Sports Medicine|March 20, 2019
Association Between Bone Marrow Lesions, Chondral Lesions, and Pain in Patients Without Radiographic Evidence of Degenerative Joint Disease Who Underwent Arthroscopic Partial MeniscectomyLeslie J Bisson, Paul Phillips, John Matthews, et al.
The Lancet. Oncology|March 29, 2011
Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trialJames W Denham, Allison Steigler, David S Lamb, et al.
American Journal of Respiratory and Critical Care Medicine|June 3, 2004
Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthmaRatko Djukanović, Susan J Wilson, Monica Kraft, et al.
Leukemia & Lymphoma|January 30, 2010
A randomized phase I clinical and biologic study of two schedules of sorafenib in patients with myelodysplastic syndrome or acute myeloid leukemia: a NCIC (National Cancer Institute of Canada) Clinical Trials Group StudyMichael Crump, David Hedley, Suzanne Kamel-Reid, et al.
The Lancet. Oncology|October 22, 2008
Time to biochemical failure and prostate-specific antigen doubling time as surrogates for prostate cancer-specific mortality: evidence from the TROG 96.01 randomised controlled trialJames W Denham, Allison Steigler, Chantelle Wilcox, et al.
Pageof 9